歌礼制药-B:创新药研发推进顺利,BD合作空间广阔
ASCLETIS(01672) 国元国际控股·2024-09-03 03:40
证 券 研 究 报 告 请务必阅读免责条款 | --- | --- | --- | |---------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...